18th Apr 2016 17:21
LONDON (Alliance News) - Silence Therapeutics PLC on Monday said Chief Executive Ali Mortazavi and Chairman Stephen Parker bought shares in the company.
Mortazavi bought 160,000 shares at 125.00 pence each, meaning he now owns a 2.78% stake in the company, equivalent to 1.9 million shares.
Taking a stake in the company, Parker bought 6,478 shares at 123.31 pence each, equal to his entire 0.01% shareholding in Silence Therapeutics.
Parker became chairman in September 2015, having been a non-executive director of Silence Therapeutics since November 2013.
Shares in Silence Therapeutics closed up 8.5% at 126.88p on Monday, the same day the CEO and chairman bought.
By Samuel Agini; [email protected]; @samuelagini
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
SLN.L